Home > Phoenix Data Systems Salary

Phoenix Data Systems Salary

  • 90
  • 96
  • 37
Phoenix Data Systems average salary is $50,073, median salary is $42,723 with a salary range from $40,290 to $67,205.
Phoenix Data Systems salaries are collected from government agencies and companies. Each salary is associated with a real job position. Phoenix Data Systems salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 3 Phoenix Data Systems Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Accountant 42,723-42,723 Pittsburgh, PA, 15201 2015 Phoenix Data Systems Accountant Salaries (2)
Phoenix Data Systems Pittsburgh, PA Salaries
It Specialist 67,205-67,205 Pittsburgh, PA, 15201 2014 Phoenix Data Systems It Specialist Salaries (1)
Phoenix Data Systems Pittsburgh, PA Salaries
Accountant 40,290-40,290 Pittsburgh, PA, 15201 2012 Phoenix Data Systems Accountant Salaries (2)
Phoenix Data Systems Pittsburgh, PA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Phoenix Data Systems salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Phoenix Data Systems Jobs
See more Phoenix Data Systems Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Phoenix Data Systems... Information
  • Phoenix Data Systems Inc
  • Industry: Information Services
  • City: King Of Prussia, PA
  • Phoenix Data Systems, Inc. (PDS) is a global leader in Electronic Data Capture (EDC) with unparalleled pharmaceutical industry experience. Founded in 1997 by a diverse and talented team from major pharmaceutical companies, PDS has conducted more than 350 trials worldwide (as of June 2006) in a broad range of therapeutic areas, and in all phases of clinical development. More than 100 new studies are scheduled for 2006.